149 related articles for article (PubMed ID: 7998085)
1. Azathioprine does not potentiate the immunosuppressive effect of 15-deoxyspergualin in rat heart allografting.
Gannedahl G; Wanders A; Wadström J; Olausson M; Ekberg H; Tufveson G
Transplant Proc; 1994 Dec; 26(6):3108-10. PubMed ID: 7998085
[No Abstract] [Full Text] [Related]
2. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
Gannedahl G; Wanders A; Carlsson M; Tufveson G
Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
[No Abstract] [Full Text] [Related]
3. Inhibition of ATG-induced experimental transplantation tolerance with LS2616.
Olausson M; Arvidsson N; Lukes D; Mjörnstedt L; Qi Z; Ekberg H; Gannedahl G; Tufveson G
Transplant Proc; 1995 Dec; 27(6):3541-3. PubMed ID: 8540092
[No Abstract] [Full Text] [Related]
4. Additive immunosuppressive effect of combined mycophenolate mofetil and cyclosporin A in experimental rat cardiac transplantation.
Ostraat O; Qi Z; Olausson M; Gannedahl G; Tufveson G; Ekberg H
Transplant Proc; 1995 Dec; 27(6):3540. PubMed ID: 8540091
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation.
Ostraat O; Qi Z; Olausson M; Tufveson G; Ekberg H
Scand J Immunol; 1997 Apr; 45(4):343-8. PubMed ID: 9105419
[TBL] [Abstract][Full Text] [Related]
6. Rat cardiac allografts protected with cyclosporin A are rejected in the presence of LS-2616 (Linomide).
Gerdin B; Wanders A; Tufveson G
Transplant Proc; 1989 Feb; 21(1 Pt 1):853-5. PubMed ID: 2650284
[No Abstract] [Full Text] [Related]
7. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
[No Abstract] [Full Text] [Related]
8. Effect of LS-2616 on the graft protection achieved by cyclosporin A, prednisolone, and 15-deoxyspergualin in heart-transplanted rats.
Wanders A; Gannedahl G; Gerdin B; Tufveson G
Transpl Int; 1992; 5 Suppl 1():S462-3. PubMed ID: 14621847
[TBL] [Abstract][Full Text] [Related]
9. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
[No Abstract] [Full Text] [Related]
10. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation.
Ueda H; Itoh S; Kusaka M; Isurugi K
Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046
[No Abstract] [Full Text] [Related]
11. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
Asano T; Murai M; Nakamura H
Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
[TBL] [Abstract][Full Text] [Related]
12. Prolonged cardiac xenograft survival by 15-deoxyspergualin combined with splenectomy.
Valdivia LA; Monden M; Gotoh M; Kubota N; Hasuike Y; Nakano Y; Okamura J; Mori T
Transplant Proc; 1989 Feb; 21(1 Pt 1):532-3. PubMed ID: 2650193
[No Abstract] [Full Text] [Related]
13. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment.
Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T
J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
[No Abstract] [Full Text] [Related]
15. Deoxyspergualin is synergistic with cyclosporin A, but not with FK506 in a rat heart allograft transplantation model.
Bersztel A; Wanders A; Wadström J; Ekberg H; Olausson M; Tufveson G; Gannedahl G
Transplant Proc; 1995 Dec; 27(6):3547. PubMed ID: 8540095
[No Abstract] [Full Text] [Related]
16. Mode of action of immunosuppressive drugs evaluated with the aid of the immunostimulator LS-2616: studies on rejecting rat cardiac allografts.
Wanders A; Gannedahl G; Gerdin B; Tufveson G
Transplant Proc; 1992 Feb; 24(1):274-5. PubMed ID: 1539280
[No Abstract] [Full Text] [Related]
17. Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Murase N; Demetris AJ; Tanabe M; Miyazawa H; Valdivia LA; Nakamura K; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):425-6. PubMed ID: 7679817
[No Abstract] [Full Text] [Related]
18. Flow cytometric analysis of graft-infiltrating lymphocytes in deoxyspergualin-treated rat renal transplants.
Takeuchi I; Chikaraishi T; Kanagawa K; Tanda K; Seki T; Togashi M; Koyanagi T
Transplant Proc; 1994 Aug; 26(4):1905-6. PubMed ID: 8066620
[No Abstract] [Full Text] [Related]
19. Suppressor cells induced by donor-specific transfusion and deoxyspergualin in cardiac xenografts from hamsters to rats.
Valdivia LA; Wonden W; Gotoh M; Tono T; Nakano Y; Okamura J; Mori T
Transplant Proc; 1991 Feb; 23(1 Pt 1):203-4. PubMed ID: 1824975
[No Abstract] [Full Text] [Related]
20. Prolongation of allograft and xenograft survival with 15-deoxyspergualin.
Corry RJ; Cutkomp J; Oberholser JH; Kapelanski DP; Wakely E
Transplant Proc; 1989 Feb; 21(1 Pt 1):530-1. PubMed ID: 2650192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
